Small cap stock which is India’s largest manufacturer of Water water-soluble films engaged in the development, manufacturing, and supplying of biodegradable and high-tech products hits 20 percent upper circuit in the day’s trade upon declaring a 116 percent jump in Net Profits in Q1FY25
Price Action
With a market capitalization of Rs. 1,425 Crores, the shares of Arrow Greentech Limited hit a 20 percent upper circuit at Rs. 944.60 per equity share, from its previous day’s close price of Rs. 787.20. It has delivered multibagger returns of 173 percent in a year.
Q1FY25 Results
Its Revenue from operations grew by 51 percent YoY from Rs. 43.86 Crores in Q1FY24 to Rs. 66.11 Crores in Q1FY25 and it grew by 31 percent QoQ from Rs. 50.62 Crores in Q4FY24 to Rs. 66.11 Crores in Q1FY25.
Its Net Profit grew by 116 percent YoY from Rs. 9.32 Crores in Q1FY24 to Rs. 20.16 Crores in Q1FY25 and it grew by 101 percent QoQ from Rs. 10.03 Crores in Q4FY24 to Rs. 20.16 Crores in Q1FY25. Its Net Profit Margin increased from 20.91 percent in Q1FY24 to 30.13 percent in Q1FY25.
Also read
About the Company
Arrow Greentech Limited is India’s largest manufacturer of water-soluble films engaged in the development, manufacturing, and supplying of biodegradable and high-tech products like cast water-soluble films, bio-compostable products, and security films. It also provides security products and intellectual property services.
It has a global presence across Europe, Asia, North & South America, and many more, it has also been granted around 31 patents across the globe for products and services across industries like Health, Hygiene, Packaging, Security, Printing, and self-adhesives
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
